Company Statement: IMS Health clarifies its market study regarding countries of origin for drugs
MLex Summary: IMS Health has provided the German Cartel Office, the Bundeskartellamt, with information in relation to its market study on countries of origin, which has come under criticism in the past...To view the full article, register now.
Already a subscriber? Click here to view full article